Sir Alan Parks Department of Physiology, St Mark's Hospital and Academic Institute, Harrow, UK.
Colorectal Dis. 2013 Dec;15(12):1504-9. doi: 10.1111/codi.12428.
Posterior tibial nerve stimulation (PTNS) has been shown to improve faecal incontinence in the short term. The optimal treatment regimen is unclear with wide variations in protocol reported in the literature. The study aimed to assess two different regimens of transcutaneous PTNS and to establish whether increasing the frequency of stimulation increases the effectiveness.
Thirty patients were randomized to receive once daily or twice weekly PTNS for a 6-week period. The treatment was carried out by the patient at home after instruction. The primary investigator was blinded to the patient allocation until the study had ended, at which point the symptoms were assessed. No further stimulation was given after 6 weeks and the patients were followed until their symptoms returned to the pre-stimulation state (baseline). The primary outcome measure was a change in the frequency of incontinent episodes.
Three patients in the daily group and none in the twice weekly group achieved complete continence. Only patients from the daily group showed a significant reduction in median (interquartile range) incontinent episodes per week from 5 (11.13) to 3.5 (4.31) (P = 0.025). There was no significant change in the frequency of defaecation nor in the ability to defer defaecation. Patients in the daily group experienced a significant improvement in the domains of lifestyle [2.2 (1.7) to 2.6 (1.65), P = 0.04] and embarrassment [1.7 (0.85) to 2.15 (0.4), P = 0.04] on the Rockwood Fecal Incontinence Quality of Life assessment. No adverse events were reported.
Transcutaneous PTNS can safely be used by the patient at home. Daily treatment may be more effective than twice weekly treatment. Larger studies are needed to investigate this further.
经皮胫后神经刺激(PTNS)已被证明可在短期内改善粪便失禁。文献中报道的方案差异很大,因此最佳治疗方案尚不清楚。本研究旨在评估两种不同的经皮 PTNS 方案,并确定增加刺激频率是否会提高疗效。
30 名患者随机分为每日或每周两次接受 PTNS 治疗,为期 6 周。治疗由患者在家中接受指导后进行。主要研究者在研究结束前对患者的分配情况保持盲态,此时评估症状。6 周后不再进行进一步的刺激,患者将一直随访,直到症状恢复到刺激前状态(基线)。主要观察指标是失禁发作频率的变化。
每日组有 3 名患者完全失禁,每周两次组无患者完全失禁。只有每日组的患者每周失禁发作的中位数(四分位间距)显著减少,从 5(11.13)减少到 3.5(4.31)(P = 0.025)。排便频率和延迟排便的能力没有显著变化。每日组患者在生活方式[2.2(1.7)至 2.6(1.65),P = 0.04]和尴尬感[1.7(0.85)至 2.15(0.4),P = 0.04]方面的生活质量评估领域有显著改善。没有报告不良事件。
经皮 PTNS 可由患者在家中安全使用。每日治疗可能比每周两次治疗更有效。需要进一步开展更大规模的研究来对此进行深入调查。